Some of these drugs are ones that are already present in New Zealand but now pose a level of risk that they need to be reclassified. Some are drugs that we know from intelligence are abroad and there is a much higher potential or risk that they will make their way into New Zealand. These are measures to make sure that, with the appropriate classification, it affords proper protection to New Zealanders who might otherwise be subject to their use or abuse. On that note, I commend the motion to the House.